John B. Bode, Director: Zevra Therapeutics ZVRA Buy · Filed 25/03/21

Trade details

Type: Insider buy
Amount: $79,600
Shares · price: 10,000 sh · $7.96 a share
Held after: 40,000 sh
Stock: Zevra Therapeutics ZVRA
Person: John B. BodeDirector
Trade date: 25/03/19
Filed: 25/03/21
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +33.3%

Zevra Therapeutics trades, last 26 weeks

What else happened in Zevra Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/17~25/04/18

John B. Bode's recent trades

John B. BodeDirector
Planned saleZevra Therapeutics
Planned sale
Zevra Therapeutics
ZVRA
$156.2K
10,516 sh
$156.2K
Filed 07/08
Traded 07/08
John B. BodeDirector
BuyZevra Therapeutics
Buy
Zevra Therapeutics
ZVRA
$45.9K
5,000 sh
$45.9K
Filed 25/08/20
Traded 25/08/19
John B. BodeDirector
BuyZevra Therapeutics
Buy
Zevra Therapeutics
ZVRA
$58.7K
10,000 sh
$58.7K
Filed 24/07/15
Traded 24/07/12
John B. BodeDirector
BuyZevra Therapeutics
Buy
Zevra Therapeutics
ZVRA
$51.3K
10,000 sh
$51.3K
Filed 23/09/06
Traded 23/09/05
John B. BodeDirector
BuyZevra Therapeutics
Buy
Zevra Therapeutics
ZVRA
$24K
4,759 sh
$24K
Filed 23/05/19
Traded 23/05/18